KRISPY KREME INC (DNUT) Fundamental Analysis & Valuation

NASDAQ:DNUT • US50101L1061

Current stock price

3.44 USD
+0.17 (+5.2%)
At close:
3.42 USD
-0.02 (-0.58%)
After Hours:

This DNUT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DNUT Profitability Analysis

1.1 Basic Checks

  • In the past year DNUT has reported negative net income.
  • DNUT had a positive operating cash flow in the past year.
  • In the past 5 years DNUT reported 4 times negative net income.
  • Of the past 5 years DNUT 4 years had a positive operating cash flow.
DNUT Yearly Net Income VS EBIT VS OCF VS FCFDNUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

  • DNUT's Return On Assets of -19.63% is on the low side compared to the rest of the industry. DNUT is outperformed by 93.65% of its industry peers.
  • Looking at the Return On Equity, with a value of -76.15%, DNUT is doing worse than 70.63% of the companies in the same industry.
Industry RankSector Rank
ROA -19.63%
ROE -76.15%
ROIC N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
DNUT Yearly ROA, ROE, ROICDNUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

  • DNUT's Gross Margin of 28.67% is on the low side compared to the rest of the industry. DNUT is outperformed by 79.37% of its industry peers.
  • DNUT's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for DNUT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
DNUT Yearly Profit, Operating, Gross MarginsDNUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. DNUT Health Analysis

2.1 Basic Checks

  • DNUT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DNUT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DNUT Yearly Shares OutstandingDNUT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
DNUT Yearly Total Debt VS Total AssetsDNUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of 0.12, we must say that DNUT is in the distress zone and has some risk of bankruptcy.
  • DNUT's Altman-Z score of 0.12 is on the low side compared to the rest of the industry. DNUT is outperformed by 86.51% of its industry peers.
  • A Debt/Equity ratio of 1.35 is on the high side and indicates that DNUT has dependencies on debt financing.
  • DNUT has a Debt to Equity ratio (1.35) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Altman-Z 0.12
ROIC/WACCN/A
WACC6.9%
DNUT Yearly LT Debt VS Equity VS FCFDNUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 0.36 indicates that DNUT may have some problems paying its short term obligations.
  • The Current ratio of DNUT (0.36) is worse than 87.30% of its industry peers.
  • DNUT has a Quick Ratio of 0.36. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of DNUT (0.30) is worse than 87.30% of its industry peers.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.3
DNUT Yearly Current Assets VS Current LiabilitesDNUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. DNUT Growth Analysis

3.1 Past

  • DNUT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -183.33%.
EPS 1Y (TTM)-183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.88%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.42% on average over the next years. This is quite good.
  • DNUT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.09% yearly.
EPS Next Y31.83%
EPS Next 2Y37.62%
EPS Next 3Y-23.24%
EPS Next 5Y12.42%
Revenue Next Year-2.13%
Revenue Next 2Y2.14%
Revenue Next 3Y4.6%
Revenue Next 5Y7.09%

3.3 Evolution

DNUT Yearly Revenue VS EstimatesDNUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
DNUT Yearly EPS VS EstimatesDNUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2030 0 0.2 0.4

More info and screens

Find the best growth stocksShow best growing peers

0

4. DNUT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DNUT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DNUT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DNUT Price Earnings VS Forward Price EarningsDNUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • 70.63% of the companies in the same industry are cheaper than DNUT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.41
DNUT Per share dataDNUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

  • DNUT's earnings are expected to decrease with -23.24% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.62%
EPS Next 3Y-23.24%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. DNUT Dividend Analysis

5.1 Amount

  • DNUT has a Yearly Dividend Yield of 4.36%, which is a nice return.
  • The stock price of DNUT dropped by -24.56% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • DNUT's Dividend Yield is rather good when compared to the industry average which is at 1.12. DNUT pays more dividend than 94.44% of the companies in the same industry.
  • DNUT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 4.36%

5.2 History

  • DNUT has been paying a dividend for over 5 years, so it has already some track record.
  • DNUT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
DNUT Yearly Dividends per shareDNUT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

  • DNUT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.5%
EPS Next 2Y37.62%
EPS Next 3Y-23.24%
DNUT Yearly Income VS Free CF VS DividendDNUT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

More info and screens

Find the best dividend stocksShow peers with best dividend

DNUT Fundamentals: All Metrics, Ratios and Statistics

KRISPY KREME INC

NASDAQ:DNUT (3/16/2026, 8:19:30 PM)

After market: 3.42 -0.02 (-0.58%)

3.44

+0.17 (+5.2%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners43.66%
Inst Owner Change1.24%
Ins Owners3.23%
Ins Owner Change0.04%
Market Cap590.17M
Revenue(TTM)N/A
Net Income(TTM)-510.43M
Analysts52.31
Price Target4.43 (28.78%)
Short Float %25.73%
Short Ratio8.11
Dividend
Industry RankSector Rank
Dividend Yield 4.36%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP-3.5%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-117.45%
Min EPS beat(2)-353.46%
Max EPS beat(2)118.57%
EPS beat(4)1
Avg EPS beat(4)-81.52%
Min EPS beat(4)-353.46%
Max EPS beat(4)118.57%
EPS beat(8)2
Avg EPS beat(8)-67.78%
EPS beat(12)5
Avg EPS beat(12)-46.53%
EPS beat(16)6
Avg EPS beat(16)-38.2%
Revenue beat(2)0
Avg Revenue beat(2)-2.13%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-1.53%
Revenue beat(4)0
Avg Revenue beat(4)-3.31%
Min Revenue beat(4)-4.66%
Max Revenue beat(4)-1.53%
Revenue beat(8)1
Avg Revenue beat(8)-1.98%
Revenue beat(12)3
Avg Revenue beat(12)-1.58%
Revenue beat(16)4
Avg Revenue beat(16)-1.39%
PT rev (1m)0%
PT rev (3m)1.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-30.6%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.38
P/FCF N/A
P/OCF 37
P/B 0.88
P/tB N/A
EV/EBITDA 20.41
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)0.09
OCFY2.7%
SpS8.94
BVpS3.91
TBVpS-4.91
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.63%
ROE -76.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.67%
FCFM N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Debt/EBITDA 12.25
Cap/Depr 83.67%
Cap/Sales 7.48%
Interest Coverage N/A
Cash Conversion 21.56%
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.3
Altman-Z 0.12
F-Score5
WACC6.9%
ROIC/WACCN/A
Cap/Depr(3y)96.05%
Cap/Depr(5y)105.48%
Cap/Sales(3y)7.25%
Cap/Sales(5y)7.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
EPS Next Y31.83%
EPS Next 2Y37.62%
EPS Next 3Y-23.24%
EPS Next 5Y12.42%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.88%
Revenue Next Year-2.13%
Revenue Next 2Y2.14%
Revenue Next 3Y4.6%
Revenue Next 5Y7.09%
EBIT growth 1Y-1143.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year501.71%
EBIT Next 3Y81.93%
EBIT Next 5Y57.43%
FCF growth 1Y-709.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85.9%
OCF growth 3Y-31.28%
OCF growth 5Y-10.72%

KRISPY KREME INC / DNUT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of KRISPY KREME INC (DNUT) stock?

ChartMill assigns a fundamental rating of 1 / 10 to DNUT.


Can you provide the valuation status for KRISPY KREME INC?

ChartMill assigns a valuation rating of 0 / 10 to KRISPY KREME INC (DNUT). This can be considered as Overvalued.


Can you provide the profitability details for KRISPY KREME INC?

KRISPY KREME INC (DNUT) has a profitability rating of 1 / 10.


What is the earnings growth outlook for KRISPY KREME INC?

The Earnings per Share (EPS) of KRISPY KREME INC (DNUT) is expected to grow by 31.83% in the next year.